Randomized Comparison of a Polymer-Free Biolimus-eluting BIOFREEDOM Stent With a Biodegradable-Polymer Sirolimus-eluting ORSIRO Stent in Patients Treated With Percutaneous Coronary Intervention
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Umirolimus (Primary) ; Sirolimus
- Indications Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms SORT OUT IX
- 23 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 22 Sep 2016 Status changed from not yet recruiting to recruiting.
- 11 Dec 2015 New trial record